Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: A review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy

Advances in Anatomic Pathology

Volumn 17, Issue 2, 2010, Pages 91-112

  Ip, Philip P C ^a   Tse, Ka Yu ^a   Tam, Kar Fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atypical leiomyoma; Cellular leiomyoma; Cotelydonoid dissecting leiomyoma; Dissecting leiomyoma; Epithelioid leiomyoma; Leiomyoma; Mitotically active leiomyoma; Myxoid leiomyoma; STUMP; Uterine smooth muscle tumor of uncertain malignant potential

Indexed keywords

CISPLATIN; DOXORUBICIN; MEDROXYPROGESTERONE; TAMOXIFEN;

CANCER RECURRENCE; CANCER RISK; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; LEIOMYOBLASTOMA; LEIOMYOMA; LEIOMYOMATOSIS; MYOMETRIUM; OVARIECTOMY; PRIORITY JOURNAL; REVIEW; UTERUS MYOMA; WORLD HEALTH ORGANIZATION;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOMA, EPITHELIOID; LEIOMYOMATOSIS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SMOOTH MUSCLE TUMOR; UTERINE NEOPLASMS;

EID: 77649088993     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181cfb901     Document Type: Review

References (156)

1. Hendrickson MR, Tavassoli FA, Kempson RL, et al. Mesenchymal tumours and related lesions. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003:236-243.
2. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535-558.
3. Perrone T, Dehner LP. Prognostically favorable "mitotically active" smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases. Am J Surg Pathol. 1988;12:1-8.
4. Prayson RA, Hart WR. Mitotically active leiomyomas of the uterus. Am J Clin Pathol. 1992;97:14-20.
5. O'Connor DM, Norris HJ. Mitotically active leiomyomas of the uterus. Hum Pathol. 1990;21:223-227.
6. Downes KA, Hart WR. Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up. Am J Surg Pathol. 1997;21:1261-1270.
7. Ip PP, Cheung AN, Clement PB. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2009;33: 992-1005.
8. Longacre TA, Hendrickson MR, Kempson RL. Predicting clinical outcome for uterine smooth muscle neoplasms with a reasonable degree of certainty. Adv Anat Pathol. 1997;4: 95-104.
9. Atkins KA, Arronte N, Darus CJ, et al. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol. 2008;32:98-102.
10. Guntupalli SR, Ramirez PT, Anderson ML, et al. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009;113:324-326.
11. Ip PP, Lam KW, Cheung CL, et al. Tranexamic acidassociated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J Surg Pathol. 2007;31:1215-1224.
12. Shapiro A, Ferenczy A, Turcotte R, et al. Uterine smoothmuscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma. Gynecol Oncol. 2004;94:818-820.
13. Ly A, McKenney JK, Longacre TA, et al. Atypical leiomyoma of the uterus: a clinicopathologic study of 46 cases [Abstract]. Mod Pathol. 2009;22:225A.
14. Amant F, Moerman P, Vergote I. Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis. Int J Gynecol Cancer. 2005;15:1210-1212.
15. Berretta R, Rolla M, Merisio C, et al. Uterine smooth muscle tumor of uncertain malignant potential: a three-case report. Int J Gynecol Cancer. 2008;18:1121-1126.
16. Ernst LM, Luo FF, Parkash V, et al. Increased global DNA methylation in symplastic leiomyomas [Abstract]. Mod Pathol. 2002;15:196A.
17. Clement PB, Young RH. Mesenchymal and mixed epithelialmesenchymal tumors of the uterine corpus and cervix. In: Atlas of Gynecologic Surgical Pathology. 2nd ed. Philadelphia: W.B. Saunders; 2007:194-235.
18. Bossard C, Jarry A, Colombeix C, et al. Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. J Clin Pathol. 2006;59:706-710.
19. Scott IS, Heath TM, Morris LS, et al. A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens. Br J Cancer. 2004;90:1583-1590.
20. Ribalta T, McCutcheon IE, Aldape KD, et al. The mitosisspecific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol. 2004;28:1532-1536.
21. Colman H, Giannini C, Huang L, et al. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol. 2006;30:657-664.
22. Veras E, Malpica A, Deavers MT, et al. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Int J Gynecol Pathol. 2009;28:316-321.
23. Hendrickson MR, Kempson RL. A diagnostic approach to smooth muscle tumors of the uterus. Curr Diagn Pathol. 2000; 6:21-30.
24. Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag; 1994:487-528.
25. Peters WA III, Howard DR, Andersen WA, et al. Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol. 1994;83:1015-1020.
26. Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 2008;27:326-332.
27. O'Neill CJ, McBride HA, Connolly LE, et al. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology. 2007;50:851-858.
28. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006; 13:8-15.
29. Bodner-Adler B, Bodner K, Czerwenka K, et al. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Gynecol Oncol. 2005;96: 62-66.
30. D'Angelo E, Spagnoli LG, Prat J. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. Hum Pathol. 2009;40:1571-1585.
31. Lee CH, Turbin DA, Sung YC, et al. A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors. Mod Pathol. 2009;22:1519-1531.
32. Prayson RA, Goldblum JR, Hart WR. Epithelioid smoothmuscle tumors of the uterus: a clinicopathologic study of 18 patients. Am J Surg Pathol. 1997;21:383-391.
33. Atkins K, Bell SW, Kempson RL. Myxoid smooth muscle tumors of the uterus [Abstract]. Mod Pathol. 2001;14:132A.
34. Clement PB. Intravenous leiomyomatosis of the uterus. Pathol Annu. 1988;23(Pt 2):153-183.
35. Canzonieri V, D'Amore ES, Bartoloni G, et al. Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis. Virchows Arch. 1994;425:541-545.
36. Biri A, Korucuoglu U, Zumrutbas N, et al. Intravenous leiomyomatosis treated with aromatase inhibitor therapy. Int J Gynaecol Obstet. 2008;101:299-300.
37. Mulvany NJ, Slavin JL, Ostor AG, et al. Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 22 cases. Int J Gynecol Pathol. 1994;13:1-9.
38. Clement PB, Young RH, Scully RE. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features. Am J Surg Pathol. 1988;12:932-945.
39. Clement PB, Scully RE. Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol. 1992;11: 163-173.
40. Norris HJ, Parmley T. Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis. A clinical and pathologic study of 14 cases. Cancer. 1975;36:2164-2178.
41. Coard KC, Fletcher HM. Leiomyosarcoma of the uterus with a florid intravascular component ("intravenous leiomyosarcomatosis"). Int J Gynecol Pathol. 2002;21:182-185.
42. Jordan LB, Al-Nafussi A, Beattie G. Cotyledonoid hydropic intravenous leiomyomatosis: a new variant leiomyoma. Histopathology. 2002;40:245-252.
43. Heninonen PK, Tama E, Nerdrum T. Intravenous leiomyomatosis. Ann Chirurg Gynaecol. 1984;73:100-104.
44. Parikh J, Lesseps A. Intravenous leiomyomatosis. J Obstet Gynaecol. 2000;20:439.
45. Barjot PJ, Refahi N, Berthet P, et al. Intravenous leiomyomatosis of the uterus: a GnRH agonist utilisation before surgery. J Obstet Gynaecol. 1998;18:492-493.
46. Mitsuhashi A, Nagai Y, Sugita M, et al. GnRH agonist for intravenous leiomyomatosis with cardiac extension. A case report. J Reprod Med. 1999;44:883-886.
47. Lo KW, Lau TK. Intracardiac leiomyomatosis. Case report and literature review. Arch Gynecol Obstet. 2001;264: 209-210.
48. Morice P, Chapelier A, Dartevelle P, et al. Late intracaval and intracardiac leiomyomatosis following hysterectomy for benign myomas treated by surgery and GnRH agonist. Gynecol Oncol. 2001;83:422-423.
49. Kayser K, Zink S, Schneider T, et al. Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch. 2000;437:284-292.
50. Patton KT, Cheng L, Papavero V, et al. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol. 2006;19:130-140.
51. Funakoshi Y, Sawabata N, Takeda S, et al. Pulmonary benign metastasizing leiomyoma from the uterus in a postmenopausal woman: report of a case. Surg Today. 2004;34:55-57.
52. Awonuga AO, Rotas M, Imudia AN, et al. Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Arch Gynecol Obstet. 2008;278: 373-376.
53. Boyce CR, Buddhdev HN. Pregnancy complicated by metastasizing leiomyoma of the uterus. Obstet Gynecol. 1973;42: 252-258.
54. Horstmann JP, Pietra GG, Harman JA, et al. Spontaneous regression of pulmonary leiomyomas during pregnancy. Cancer. 1977;39:314-321.
55. Cramer SF, Meyer JS, Kraner JF, et al. Metastasizing leiomyoma of the uterus. S-phase fraction, estrogen receptor, and ultrastructure. Cancer. 1980;45:932-937.
56. Banner AS, Carrington CB, Emory WB, et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med. 1981;305:204-209.
57. Evans AJ, Wiltshaw E, Kochanowski SJ, et al. Metastasizing leiomyoma of the uterus and hormonal manipulations. Case report. Br J Obstet Gynaecol. 1986;93:646-648.
58. Abell MR, Littler ER. Benign metastasizing uterine leiomyoma. Multiple lymph nodal metastases. Cancer. 1975;36: 2206-2213.
59. Deppe G, Clachko M, Deligdisch L, et al. Uterine fibroleimoyomata with aortic lymph node metastases. Int J Gynaecol Obstet. 1980;18:1-3.
60. Gatti JM, Morvan G, Henin D, et al. Leiomyomatosis metastasizing to the spine. A case report. J Bone Joint Surg Am. 1983;65:1163-1165.
61. Barter JF, Szpak C, Creasman WT. Uterine leiomyomas with retroperitoneal lymph node involvement. South Med J. 1987; 80:1320-1322.
62. Horiuchi K, Yabe H, Mukai M, et al. Multiple smooth muscle tumors arising in deep soft tissue of lower limbs with uterine leiomyomas. Am J Surg Pathol. 1998;22:897-901.
63. Maltby JD, Misra D, Knight FH. "Metastasizing leiomyoma" occurring as a mediastinal mass. Case report. Mo Med. 1980;77:304-306.
64. Esteban JM, Allen WM, Schaerf RH. Benign metastasizing leiomyoma of the uterus: histologic and immunohistochemical characterization of primary and metastatic lesions. Arch Pathol Lab Med. 1999;123:960-962.
65. de Ruiter GC, Scheithauer BW, Amrami KK, et al. Benign metastasizing leiomyomatosis with massive brachial plexus involvement mimicking neurofibromatosis type 1. Clin Neuropathol. 2006;25:282-287.
66. Tori M, Akamatsu H, Mizutani S, et al. Multiple benign metastasizing leiomyomas in the pelvic lymph nodes and biceps muscle: report of a case. Surg Today. 2008;38:432-435.
67. Sapmaz F, Ergin M, Katrancioglu O, et al. Benign metastasizing leiomyoma. Lung. 2008;186:271-273.
68. Lawson LM, Tiwari P, Filipenko JD. An unusual cause of an incidental lung mass. Can Respir J. 2003;10:276-277.
69. Lipton JH, Fong TC, Burgess KR. Miliary pattern as presentation of leiomyomatosis of the lung. Chest. 1987;91:781-782.
70. Moon H, Park SJ, Lee HB, et al. Pulmonary benign metastasizing leiomyoma in a postmenopausal woman. Am J Med Sci. 2009;338:72-74.
71. Cho KR, Woodruff JD, Epstein JI. Leiomyoma of the uterus with multiple extrauterine smooth muscle tumors: a case report suggesting multifocal origin. Hum Pathol. 1989;20: 80-83.
72. Clark DH, Weed JC. Metastasizing leiomyoma: a case report. Am J Obstet Gynecol. 1977;127:672-673.
73. Konis EE, Belsky RD. Metastasizing leiomyoma of the uterus. Report of a case. Obstet Gynecol. 1966;27:442-446.
74. White SH, Ibrahim NB, Forrester-Wood CP, et al. Leiomyomas of the lower respiratory tract. Thorax. 1985;40:306-311.
75. Bodner-Adler B, Bartl M, Wagner G. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma? Anticancer Res. 2009; 29:495-496.
76. Lee HJ, Choi J, Kim KR. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory. Int J Gynecol Pathol. 2008;27: 340-345.
77. Arif S, Ganesan R, Spooner D. Intravascular leiomyomatosis and benign metastasizing leiomyoma: an unusual case. Int J Gynecol Cancer. 2006;16:1448-1450.
78. Koh DM, Burn PR, King DM. Benign metastasizing leiomyoma with intracaval leiomyomatosis. Br J Radiol. 2000;73: 435-437.
79. Tietze L, Gunther K, Horbe A, et al. Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease. Hum Pathol. 2000;31:126-128.
80. Nucci MR, Drapkin R, Dal Cin P, et al. Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. Am J Surg Pathol. 2007;31:737-743.
81. Fukunaga M. Benign "metastasizing" lipoleiomyoma of the uterus. Int J Gynecol Pathol. 2003;22:202-204.
82. Abu-Rustum NR, Curtin JP, Burt M, et al. Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol. 1997;89:850-852.
83. Nasu K, Tsuno A, Takai N, et al. A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole. Arch Gynecol Obstet. 2009;279:255-257.
84. Rivera JA, Christopoulos S, Small D, et al. Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature. J Clin Endocrinol Metab. 2004;89:3183-3188.
85. Clement PB. The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol. 2000;19:39-55.
86. Clement PB, Young RH, Scully RE. Nontrophoblastic pathology of the female genital tract and peritoneum associated with pregnancy. Semin Diagn Pathol. 1989;6:372-406.
87. Myles JL, Hart WR. Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage. Am J Surg Pathol. 1985;9:798-805.
88. Norris HJ, Hilliard GD, Irey NS. Hemorrhagic cellular leiomyomas ("apoplectic leiomyoma") of the uterus associated with pregnancy and oral contraceptives. Int J Gynecol Pathol. 1988;7:212-224.
89. Colgan TJ, Pendergast S, LeBlanc M. The histopathology of uterine leiomyomas following treatment with gonadotropinreleasing hormone analogues. Hum Pathol. 1993;24:1073-1077.
90. Hart WR. Problematic uterine smooth muscle neoplasms [letter]. Am J Surg Pathol. 1997;21:252-255.
91. Sreenan JJ, Prayson RA, Biscotti CV, et al. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. Am J Surg Pathol. 1996;20:427-432.
92. Gutmann JN, Thornton KL, Diamond MP, et al. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata. Fertil Steril. 1994;61:622-626.
93. Cohen D, Mazur MT, Jozefczyk MA, et al. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy. J Reprod Med. 1994;39: 377-380.
94. Crow J, Gardner RL, McSweeney G, et al. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin. Int J Gynecol Pathol. 1995;14:235-242.
95. Kalir T, Goldstein M, Dottino P, et al. Morphometric and electron-microscopic analyses of the effects of gonadotropinreleasing hormone agonists on uterine leiomyomas. Arch Pathol Lab Med. 1998;122:442-446. (Pubitemid 28237537)
96. Rein MS, Barbieri RL, Welch W, et al. The concentrations of collagen-associated amino acids are higher in GnRH agonisttreated uterine myomas. Obstet Gynecol. 1993;82:901-905.
97. Przybora LA. Leiomyosarcoma in situ of the uterus. Cancer. 1961;14:483-492.
98. Evans HL, Chawla SP, Simpson C, et al. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988;62:2239-2247.
99. Christopherson WM, Williamson EO, Gray LA. Leiomyosarcoma of the uterus. Cancer. 1972;29:1512-1517.
100. Hart WR, Billman JK Jr. A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas. Cancer. 1978;41:1902-1910.
101. Mazur MT, Priest JB. Clear cell leiomyoma (leiomyoblastoma) of the uterus: ultrastructural observations. Ultrastruct Pathol. 1986;10:249-255.
102. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological Typing of Female Genital Tract Tumours. 2nd ed. Berlin: Springer-Verlag; 1994.
103. Mazur MT, Kraus FT. Histogenesis of morphologic variations in tumors of the uterine wall. Am J Surg Pathol. 1980; 4:59-74.
104. Parker RL, Young RH, Clement PB. Skeletal muscle-like and rhabdoid cells in uterine leiomyomas. Int J Gynecol Pathol. 2005;24:319-325.
105. Brooks JJ, Wells GB, Yeh IT, et al. Bizarre epithelioid lipoleiomyoma of the uterus. Int J Gynecol Pathol. 1992;11:144-149.
106. McDonald AG, Cin PD, Ganguly A, et al. Liposarcoma arising in uterine lipoleiomyoma: a report of three cases [Abstract]. Mod Pathol. 2009;22:228A.
107. Kawaguchi K, Fujii S, Konishi I, et al. Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol. 1989;160:637-641.
108. Tiltman AJ. The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol. 1985;4:89-96.
109. Liu IF, Yen YS, Cheng YM, et al. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen. Taiwan J Obstet Gynecol. 2006; 45:167-169.
110. Oliva E, Young RH, Clement PB, et al. Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol. 1995;19: 757-768.
111. Toledo G, Oliva E. Smooth muscle tumors of the uterus: a practical approach. Arch Pathol Lab Med. 2008;132:595-605.
112. Oliva E, Young RH, Amin MB, et al. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol. 2002;26:403-412.
113. Oliva E, Clement PB, Young RH. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol. 2000;7:257-281.
114. Saeed AS, Hanaa B, Faisal AS, et al. Cotyledonoid dissecting leiomyoma of the uterus: a case report of a benign uterine tumor with sarcomalike gross appearance and review of literature. Int J Gynecol Pathol. 2006;25:262-267.
115. Roth LM, Reed RJ, Sternberg WH. Cotyledonoid dissecting leiomyoma of the uterus. The Sternberg tumor. Am J Surg Pathol. 1996;20:1455-1461.
116. David MP, Homonnai TZ, Deligdish L, et al. Grape-like leiomyomas of the uterus. Int Surg. 1975;60:238-239.
117. Roth LM, Reed RJ. Dissecting leiomyomas of the uterus other than cotyledonoid dissecting leiomyomas: a report of eight cases. Am J Surg Pathol. 1999;23:1032-1039.
118. Roth LM, Reed RJ. Cotyledonoid leiomyoma of the uterus: report of a case. Int J Gynecol Pathol. 2000;19:272-275.
119. Brand AH, Scurry JP, Planner RS, et al. Grapelike leiomyoma of the uterus. Am J Obstet Gynecol. 1995;173:959-961.
120. Kim MJ, Park YK, Cho JH. Cotyledonoid dissecting leiomyoma of the uterus: a case report and review of the literature. J Korean Med Sci. 2002;17:840-844.
121. Stewart KA, Ireland-Jenkin K, Quinn M, et al. Cotyledonoid dissecting leiomyoma. Pathology. 2003;35:177-179.
122. Shelekhova KV, Kazakov DV, Michal M. Cotyledonoid dissecting leiomyoma of the uterus with intravascular growth: report of two cases. Virchows Arch. 2007;450: 119-121.
123. Clement PB, Young RH, Scully RE. Diffuse, perinodular, and other patterns of hydropic degeneration within and adjacent to uterine leiomyomas. Problems in differential diagnosis. Am J Surg Pathol. 1992;16:26-32.
124. Persaud V, Arjoon PD. Uterine leiomyoma. Incidence of degenerative change and a correlation of associated symptoms. Obstet Gynecol. 1970;35:432-436.
125. Lamb CA, Young RH. Myxoid leiomyomas of the uterus. A report of 14 cases [Abstract]. Mod Pathol. 2009;22:223A.
126. Kurman RJ, Norris HJ. Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases. Cancer. 1976;37:1853-1865.
127. Hyde KE, Geisinger KR, Marshall RB, et al. The clear-cell variant of uterine epithelioid leiomyoma. An immunohistologic and ultrastructural study. Arch Pathol Lab Med. 1989; 113:551-553.
128. Kaminski PF, Tavassoli FA. Plexiform tumorlet: a clinical and pathologic study of 15 cases with ultrastructural observations. Int J Gynecol Pathol. 1984;3:124-134.
129. Seidman JD, Thomas RM. Multiple plexiform tumorlets of the uterus. Arch Pathol Lab Med. 1993;117:1255-1256.
130. Morelli L, Pusiol T, Parolari AM, et al. Plexiform lipoleiomyoma of the uterus: first case report. Arch Gynecol Obstet. 2006;274:117-118.
131. Jones MW, Norris HJ. Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol. 1995; 14:243-249.
132. Seidman JD, Yetter RA, Papadimitriou JC. Epithelioid component of uterine leiomyosarcoma simulating metastatic carcinoma. Arch Pathol Lab Med. 1992;116:287-290.
133. de Leval L, Waltregny D, Boniver J, et al. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. Am J Surg Pathol. 2006;30:319-327.
134. Silva EG, Deavers MT, Bodurka DC, et al. Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol. 2004;28: 244-249.
135. Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558-1575.
136. Bosincu L, Rocca PC, Martignoni G, et al. Perivascular epithelioid cell (PEC) tumors of the uterus: a clinicopathologic study of two cases with aggressive features. Mod Pathol. 2005;18:1336-1342.
137. Vang R, Kempson RL. Perivascular epithelioid cell tumor ("PEComa") of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol. 2002;26:1-13.
138. Oliva E, Nielson GP, Clement PB, et al. Epithelioid smooth muscle tumors of the uterus. A clinicopathologic analysis of 80 cases [Abstract]. Mod Pathol. 1997;10:107A.
139. Atkins K, Bell SW, Kempson RL, et al. Epithelioid smooth muscle tumors of the uterus [Abstract]. Mod Pathol. 2001;14: 132A.
140. Kelly HA, Cullen TS, eds. In: Myomata of the Uterus. Philadelphia: W.B. Saunders; 1909.
141. Haines M, Taylor CW, eds. In: Gynaecological Pathology. 2nd ed. New York: Churchhill Livingstone; 1975.
142. Murray HL, Glynn E. A case of complete fibromyomatosis of the corpus uteri. J. Obstet Gynaecol Brit Emp. 1924;31: 398-401.
143. Baschinsky DY, Isa A, Niemann TH, et al. Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol. 2000;31:1429-1432.
144. Thielen BK, Barker DF, Nelson RD, et al. Deletion mapping in Alport syndrome and Alport syndrome-diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth. Hum Mutat. 2003;22:419.
145. Mulvany NJ, Ostor AG, Ross I. Diffuse leiomyomatosis of the uterus. Histopathology. 1995;27:175-179.
146. Robles-Frias A, Severin CE, Robles-Frias MJ, et al. Diffuse uterine leiomyomatosis with ovarian and parametrial involvement. Obstet Gynecol. 2001;97:834-835.
147. Clement PB, Young RH. Diffuse leiomyomatosis of the uterus: a report of four cases. Int J Gynecol Pathol. 1987;6: 322-330.
148. Shimizu Y, Yomo H, Kita N, et al. Successful pregnancy after gonadotropin-releasing hormone analogue and hysteroscopic myomectomy in a woman with diffuse uterine leiomyomatosis. Arch Gynecol Obstet. 2009;280:145-147.
149. Yen CF, Lee CL, Wang CJ, et al. Successful pregnancies in women with diffuse uterine leiomyomatosis after hysteroscopic management. Fertil Steril. 2007;88:1667-1673.
150. Dionigi A, Oliva E, Clement PB, et al. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol 2002;26:567-581.
151. Thomas EO, Gordon J, Smith-Thomas S, et al. Diffuse uterine leiomyomatosis with uterine rupture and benign metastatic lesions of the bone. Obstet Gynecol. 2007;109:528-530.
152. Lapan B, Solomon L. Diffuse leiomyomatosis of the uterus precluding myomectomy. Obstet Gynecol. 1979;53:82S-84S.
153. Fedele L, Zamberletti D, Carinelli S, et al. Diffuse uterine leiomyomatosis. Acta Eur Fertil. 1982;13:125-131.
154. Kido A, Monma C, Togashi K, et al. Uterine arterial embolization for the treatment of diffuse leiomyomatosis. J Vasc Interv Radiol. 2003;14:643-647.
155. Fedele L, Bianchi S, Zanconato G, et al. Conservative treatment of diffuse uterine leiomyomatosis. Fertil Steril. 2004;82: 450-453.
156. Domnitz SW, Roth JA, Corwin LJ. Diffuse leiomyomatosis of the uterus in pregnancy. A case report. J Reprod Med. 1994;39:61-66.